KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares Issued
Ratios

AbbVie (ABBV) Long-Term Debt Issuances (2016 - 2025)

AbbVie (ABBV) has disclosed Long-Term Debt Issuances for 7 consecutive years, with $4.0 billion as the latest value for Q1 2025.

  • Quarterly Long-Term Debt Issuances fell 73.31% to $4.0 billion in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 billion through Dec 2025, down 76.45% year-over-year, with the annual reading at $4.0 billion for FY2025, 76.45% down from the prior year.
  • Long-Term Debt Issuances for Q1 2025 was $4.0 billion at AbbVie, up from $2.0 billion in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $15.0 billion in Q1 2024, with the low at $1.0 billion in Q3 2021.
  • Average Long-Term Debt Issuances over 4 years is $4.8 billion, with a median of $2.0 billion recorded in 2022.
  • Peak annual rise in Long-Term Debt Issuances hit 73.31% in 2025, while the deepest fall reached 73.31% in 2025.
  • Over 4 years, Long-Term Debt Issuances stood at $1.0 billion in 2021, then soared by 100.0% to $2.0 billion in 2022, then changed by 0.0% to $2.0 billion in 2024, then surged by 99.7% to $4.0 billion in 2025.
  • According to Business Quant data, Long-Term Debt Issuances over the past three periods came in at $4.0 billion, $2.0 billion, and $15.0 billion for Q1 2025, Q4 2024, and Q1 2024 respectively.